Stock Price Quote

MARKSANS PHARMA LTD.

NSE : MARKSANSBSE : 524404ISIN CODE : INE750C01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE67.40-0.6 (-0.88 %)
PREV CLOSE ( ) 68.00
OPEN PRICE ( ) 67.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 118814
TODAY'S LOW / HIGH ( )66.75 68.70
52 WK LOW / HIGH ( )48 97.5
NSE67.40-0.7 (-1.03 %)
PREV CLOSE( ) 68.10
OPEN PRICE ( ) 68.00
BID PRICE (QTY) 67.40 (671)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1182106
TODAY'S LOW / HIGH( ) 66.70 68.95
52 WK LOW / HIGH ( )48.1 97.6
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992
Management Info
Mark Saldanha - Chairman Mark Saldanha - Managing Director
Registered Office

Address 11th Floor, " Grandeur ",Opp. Gundecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W),
Mumbai,
Maharashtra-400053

Phone 022- 40012000

Email info@marksanspharma.com

Website www.marksanspharma.com

Registrars Details
Bigshare Services Pvt Ltd
Bharat Tin Works Building,1st floor, Opp. Vasant Oasis,Andheri (E),Mumbai
Listing : BSE, NSE

NEWS

13Oct Marksans Pharma informs about complian
Marksans Pharma has informed that it enclosed a Certificate under Regula..
31Aug Marksans Pharma informs about details
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..
30Aug Marksans Pharma informs about notice o
Marksans Pharma has informed that the Register of Members & Share Tr..
27Aug Marksans Pharma, Wipro and Ashok Leyla
Marksans Pharma has received approval from USFDA for an Abbreviated New..
27Aug Marksans Pharma gains on getting appro
Marksans Pharma is currently trading at Rs. 71.90, up by 0.25 points or..

Financials

in Millions
QTR Jun 21 ANNUAL 21
Net Profit289.06983.81
Gross Profit 341.78 1243.3
Operating Profit 390.371448.68
Net Sales 1472.215995.48

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  20746.95 (0.93%)
M.Cap ( in Cr)44085.82
Ajanta Pharma (BSE)
peergroup  2215.40 (2.45%)
M.Cap ( in Cr)19171.13
Sanofi India (BSE)
peergroup  8117.95 (0.35%)
M.Cap ( in Cr)18696.14
Mercury Laboratories (BSE)
peergroup  718.00 (3.16%)
M.Cap ( in Cr)86.16
Suven Pharma (BSE)
peergroup  533.95 (1.75%)
M.Cap ( in Cr)13592.50

Shareholding Pattern

NON-INSTITUTION 48.58%
PROMOTERS 48.25%
MUTUAL FUNDS/UTI 0.34%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
Quant Small Cap Fund(G)0.83

About Marksans Pharma Ltd.

Marksans Pharma Ltd. was incorporated in the year 1992. Its today's share price is 67.4. Its current market capitalisation stands at Rs 2758.77 Cr. In the latest quarter, company has reported Gross Sales of Rs. 5995.48 Cr and Total Income of Rs.6307.03 Cr. The company's management includes Sunny Sharma, Harshavardhan Panigrahi, Meena Surana, Abhinna Sundar Mohanty, Digant Mahesh Parikh, Seetharama Raju Buddharaju, Varddhman Vikramaditya Jain, Sandra Saldanha, Mark Saldanha, Mark Saldanha.

It is listed on the BSE with a BSE Code of 524404 , NSE with an NSE Symbol of MARKSANS and ISIN of INE750C01026. It's Registered office is at 11th Floor, " Grandeur ",Opp. Gundecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W)Mumbai-400053, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Bhuta Shah & Co LLP, NK Mittal & Associates, VS Lalpuria & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)